Bayer MaterialScience recently completed its acquisition of PolyBioMed Ltd. based in Sheffield, UK, expanding its product portfolio for medical technology. PolyBioMed, formerly a subsidiary of Lombard Medical Technologies plc, provides polymer coatings, surface treatments and biomaterials to the medical device industry. The acquisition gives Bayer MaterialScience access to application areas such as coronary drug-eluting stents, plus catheter systems for interventional cardiology, urology and neurology. The aim is to provide innovative materials which can enhance design, manufacturing and end-use performance for a variety of medical devices.
Bayer Invests in Products for Medical Technology
Published April 6, 2010
blog comments powered by Disqus